Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Aurobindo Pharma pulled up by USFDA for repeated CGMP failures

      Aurobindo Pharma pulled up by USFDA for repeated CGMP failures

      Medical Dialogues Bureau4 July 2019 10:00 AM IST
      The repeated failures at multiple sites of Aurobindo Pharma demonstrate that management oversight and control over the manufacture of drugs are...
      Lupin gets USFDA nod for generic versions of Sensipar tablets, Omidria intraocular solution

      Lupin gets USFDA nod for generic versions of Sensipar tablets, Omidria intraocular solution

      Medical Dialogues Bureau4 July 2019 9:45 AM IST
      Cinacalcet tablets are a generic version of Amgen Inc's Sensipar tablets in the same strengths, said Lupin.New Delhi: Drug firm Lupin on Wednesday...
      Biovac finalizes deal to manufacture Pfizer, Sanofi vaccines

      Biovac finalizes deal to manufacture Pfizer, Sanofi vaccines

      Medical Dialogues Bureau4 July 2019 9:00 AM IST
      The new production lines follow years of technology transfers and skills upgrades with partners Sanofi and Pfizer in Africa’s largest pharmaceutical...
      Patients save Rs 12447 crore due to price fixation of essential medicines by NPPA

      Patients save Rs 12447 crore due to price fixation of essential medicines by NPPA

      Medical Dialogues Bureau3 July 2019 2:23 PM IST
      Highlighting the role of the National Pharmaceutical Pricing Authority (NPPA), Gowda said the Authority has taken important measures to check prices...
      Sanofi gets European nod for Libtayo to treat cutaneous squamous cell carcinoma

      Sanofi gets European nod for Libtayo to treat cutaneous squamous cell carcinoma

      Medical Dialogues Bureau3 July 2019 9:30 AM IST
      Libtayo is being jointly developed by Sanofi and Regeneron under a global collaboration agreement.PARIS: The European Commission (EC) has granted...
      Merck Foundation, First Lady of Guinea collaborate to launch first Merck Health Media Training

      Merck Foundation, First Lady of Guinea collaborate to launch first Merck Health Media Training

      Medical Dialogues Bureau3 July 2019 9:00 AM IST
      "The training program is a part of 'Merck More than a Mother' community awareness Program and was organized for the first time in Guinea for local...
      Centre ask States not to partner with Philip Morris-led anti-smoking group

      Centre ask States not to partner with Philip Morris-led anti-smoking group

      Medical Dialogues Bureau2 July 2019 9:15 AM IST
      India's federal health ministry has sent a letter, dated June 24, to chief secretaries of all states, saying they should not partner with FSFW and...
      CMA refers Illumina-Pacific Biosciences deal for in-depth investigation

      CMA refers Illumina-Pacific Biosciences deal for in-depth investigation

      Medical Dialogues Bureau1 July 2019 9:00 AM IST
      The Competition and Markets Authority (CMA) said it would refer the merger to a second phase investigation after the companies refused to address...
      US government seeks part of Oklahoma $270 million opioid settlement

      US government seeks part of Oklahoma $270 million opioid settlement

      Medical Dialogues Bureau30 Jun 2019 9:00 AM IST
      It's not clear how much of the state's settlement the federal government is seeking or where the money would come from. Oklahoma's settlement in March...
      USFDA Warning: Medtronic recalls insulin pumps over cybersecurity vulnerabilities

      USFDA Warning: Medtronic recalls insulin pumps over cybersecurity vulnerabilities

      Medical Dialogues Bureau29 Jun 2019 1:49 PM IST
      The recalled pumps are Medtronic's MiniMed 508 insulin pump and MiniMed Paradigm series insulin pumps. Medtronic is unable to adequately update the...
      Court hears appeal on Pharma Bro Martin Shkreli fraud case

      Court hears appeal on Pharma Bro Martin Shkreli fraud case

      Medical Dialogues Bureau29 Jun 2019 9:00 AM IST
      NEW YORK: A federal appeals court heard arguments Friday over whether the securities fraud conviction against former drug company CEO Martin Shkreli,...
      Glenmark Pharma receives USFDA approval for generic version of Vytorin tablets

      Glenmark Pharma receives USFDA approval for generic version of Vytorin tablets

      Medical Dialogues Bureau28 Jun 2019 12:39 PM IST
      The approved product, Ezetimibe and Simvastatin tablets, is a generic version of MSD International's Vytorin tablets.New Delhi: Glenmark...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok